Philip Wilson, DO
Ophthalmology · Jefferson City, MONPI 1114902327
Payments from drug & device makers
Across 125 payments — averaging $29.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$681
- AbbVie$636
- Rxsight Inc$330
- Regeneron Healthcare Solutions, Inc.$329
- Tarsus Pharmaceuticals, Inc.$306
- Bausch & Lomb Americas Inc.$240
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,62799%
- Gifts$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 28 | $681 |
| AbbVie(2 entities) | 26 | $636 |
| Rxsight Inc | 3 | $330 |
| Regeneron Healthcare Solutions, Inc. | 5 | $329 |
| Tarsus Pharmaceuticals, Inc. | 11 | $306 |
| Bausch & Lomb Americas Inc. | 6 | $240 |
| Johnson & Johnson Surgical Vision, Inc. | 6 | $220 |
| Biogen | 5 | $114 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $106 |
| NEW World Medical,inc. | 2 | $105 |
| Genentech USA, Inc. | 5 | $88 |
| Novartis | 4 | $86 |
| Apellis Pharmaceuticals, Inc. | 3 | $50 |
| Sun Pharmaceutical Industries Inc. | 2 | $47 |
| Dompe US, Inc. | 2 | $45 |
| Mallinckrodt Hospital Products Inc. | 2 | $42 |
| Amgen(2 entities) | 2 | $40 |
| Glaukos Corporation | 2 | $39 |
| Ocular Therapeutix, Inc. | 2 | $30 |
| Thea Pharma Inc. | 1 | $20 |
| Rayner Intraocular Lenses Limited | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Eyevance Pharmaceuticals LLC | 1 | $19 |
| Johnson & Johnson Vision Care, Inc. | 1 | $18 |
| Aerie Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,646 in reported general payments places this provider in the 65th percentile of 286 ophthalmology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 145 | $1,438 |
| Fluorometholone | 12 | $872 |
| Brimonidine Tartrate | 11 | $804 |
| Prednisolone Acetate | 14 | $683 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 24 | $317 |
| Timolol Maleate | 24 | $300 |
| Dorzolamide Hcl | 13 | $234 |
| Doxycycline Monohydrate | 11 | $88 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Jefferson City
- Matthew LewisJefferson City$9K
- Nancy HolekampChesterfield$2.7M
- Steven SilversteinKansas City$1.6M
- Joseph TauberKansas City$1.3M
- Steven CouchSaint Louis$1.2M
- Andrew MoyesKansas City$1.1M
- Ranjan MalhotraSaint Louis$964K
- Navin TekwaniSaint Louis$957K
- Joseph GiraDes Peres$926K
- Michael KorenfeldWashington$821K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.